CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN®
NTAP Designation Expected to Support Medicare Patient Access, Treatment Center Economics and Commercial Adoption NTAP Designation Expected to Support Medicare Patient Access, Treatment Center Economics and Commercial Adoption
Covered in this story
Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.